Fenofibrate

Fenofibrate (Fenofibrate), also known as prolipen, is a blood lipid regulator of Clobetin ester, and gefefibrate, benzabate belong to the same class of lipid regulating drugs, in 1975 for the first time in clinical use, 1998 in the United States, has been listed in as many as 85 countries and regions in the world. This product is one of the first choice drugs to reduce triglycerides, and can also reduce blood uric acid level, and has a good effect on the treatment of type 2 diabetes and metabolic syndrome, and has a good market prospect. China has approved the number of fenoate preparation production enterprises Chemicalbook industry up to hundreds, of which the import of only one preparation approval, the manufacturer is France LaboratoriesFournier company (original research). Most of the listed dosage forms are tablets, capsules and granules. The survey shows that Liping ®, produced by LaboratoriesFournier, France, occupies nearly 80-90% of the domestic market share, and the rest of the market is divided by other domestic brands of products, ranking first is Shanghai Aidifa Pharmaceutical Co., Ltd. of Libefei ®, the company's production of sustained release capsules.